Secure IBD

97 posts

Secure IBD

@SecureIBD

SECURE-IBD is an international database that captured the natural history and outcomes of #COVID19 occurring in #IBD patients from March 2020 to January 2022.

UNC- Chapel Hill Katılım Nisan 2020

135 Takip Edilen758 Takipçiler

Sabitlenmiş Tweet

Secure IBD@SecureIBD·14 Eyl

Our analysis on the impact of #IBD medications in >6000 patients with #COVID19 in our registry is out in @AGA_Gastro!

Ryan Ungaro MD MS@ryanungaro

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of Over 6,000 Patients from an International Registry. Latest from SECURE-IBD. #relatedArticles" target="_blank" rel="nofollow noopener">gastrojournal.org/article/S0016-…

English

Secure IBD@SecureIBD·24 Oca

@EJBrenner_MD @ManasiAgrawalMD @ryanungaro @MichaelKappel12 @JeanFredericCo1 @Siew_C_Ng @gilkaplan @Flaviostein @JamesLewisGIEpi @IOIBD1 @CrohnsColitisFn @NASPGHAN @Y_ECCO_IBD

QAM

Secure IBD@SecureIBD·24 Oca

It is time to close down reporting to the SECURE-IBD database. We are proud of SECURE-IBD’s contributions and incredibly grateful for your help. This initiative was not possible without the support of the entire #IBD community. covidibd.org

English

Secure IBD retweetledi

Uma Mahadevan@UmaMahadevanIBD·30 Eki

Great talk by ⁦@ryanungaro⁩ ⁦@SecureIBD⁩ on COVID-IBD. Disease activity and steroids biggest risk factors for poor outcomes. ⁦@ucsfibd⁩

English

Secure IBD@SecureIBD·18 Eki

The strength of collaboration! Study pooling data on TNFi +/- other therapies and #COVID19 outcomes in >6000 patients with immune-mediated inflammatory diseases @rheum_covid @PsoProtect

JAMA Network Open@JAMANetworkOpen

Pooled results from @rheum_covid, @SecureIBD, and @PsoProtect, representing >6000 patients with immune-mediated inflammatory disease and #COVID19, support TNFi monotherapy use during the pandemic. @IzadiZara @EJBrenner_MD @JYazdanyMD @MichaelKappel12 ja.ma/3ATO9ZC

English

Secure IBD@SecureIBD·28 Eyl

Great collaboration with @amandaricciuto @ericbenchimol @DrNickKennedy @ibdseb and others!

Eric Benchimol@ericbenchimol

New @SecureIBD study from @amandaricciuto at @SickKidsNews IBD Centre: younger patients w.more severe inflammation at-risk for severe #COVID19 (controlling for medications) @gilkaplan @MichaelKappel12 @ManasiAgrawalMD @EJBrenner_MD @ekuenzig @DrNickKennedy academic.oup.com/ecco-jcc/advan…

English

Secure IBD@SecureIBD·5 Ağu

New GI symptoms in individuals with #IBD who get #COVID19 do not correlate with death or other severe outcomes. Read our new pub here 👉🏻 academic.oup.com/ibdjournal/adv… @ryanungaro @ManasiAgrawalMD @EJBrenner_MD @MichaelKappel12 @JeanFredericCo1

English

Secure IBD retweetledi

Gastroenterology Learning Network@Gastro_Network·13 Tem

@EJBrenner_MD and @ManasiAgrawalMD on #COVID19 outcomes and racial disparities among #IBD populations 🔊ow.ly/mh1D50Fui7m @SecureIBD @wingyanjoyce @gilkaplan @Siew_C_Ng @Flaviostein @JamesLewisGIEpi @HuntKissous @IreneModesto @ryanungaro @JeanFredericCo1 @MichaelKappel12

Gastroenterology Learning Network tweet media

English

Secure IBD@SecureIBD·2 Tem

Rajen Parekh, a recent high school graduate, reported on the impact of individual comorbid conditions on #COVID19 outcomes in #IBD @DDS_Journal What an accomplishment! pubmed.ncbi.nlm.nih.gov/34181165/ @EJBrenner_MD @ryanungaro @ManasiAgrawalMD @JeanFredericCo1 @MichaelKappel12

English

Secure IBD@SecureIBD·17 Haz

@ManasiAgrawalMD @EJBrenner_MD on our study on racial ethnic disparities in #COVID19 outcomes in #IBD @medpagetoday medpagetoday.com/aga/inflammato… @wingyanjoyce @ryanungaro @MichaelKappel12 @JeanFredericCo1 @Siew_C_Ng @gilkaplan @Flaviostein @JamesLewisGIEpi @HuntKissous @IreneModesto

English

Secure IBD@SecureIBD·7 Haz

@ManasiAgrawalMD @EJBrenner_MD @wingyanjoyce @Siew_C_Ng @gilkaplan @Flaviostein @JamesLewisGIEpi @JeanFredericCo1 @MichaelKappel12

QAM

Secure IBD@SecureIBD·7 Haz

➡️a reminder to take into account social determinants of health in clinical practice ➡️emphasizes the urgent need for policy change towards equitable healthcare for all Health is a human right.

English

Secure IBD@SecureIBD·7 Haz

Disparities in #COVID19 outcomes by race and ethnicity, now published in @AGA_CGH ➡️Hispanic & non-Hispanic black individuals with #IBD had worse #COVID19 outcomes ➡️driven in part by non-IBD comorbidities cghjournal.org/article/S1542-…

English

Secure IBD retweetledi

Neera Gupta, MD, MAS@NeeraGuptaMD·21 May

Dr @MichaelKappel12 discussing Outcomes in Patients with #IBD and #COVID19 by Age #DDW21 #DDW2021 @secureIBD

English

Secure IBD@SecureIBD·21 May

NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN... by @ryanungaro DDW ePoster Library; May 21 2021; 319648 eposters.ddw.org/ddw/2021/ddw-2… @EJBrenner_MD @ManasiAgrawalMD @MichaelKappel12 @JeanFredericCo1

English

Secure IBD@SecureIBD·21 May

COVID-19 OUTCOMES AMONG RACIAL AND ETHNIC... by @EJBrenner_MD DDW ePoster Library; May 21 2021; 319659 Poster of Distinction! eposters.ddw.org/ddw/2021/ddw-2… @ManasiAgrawalMD @ryanungaro @wingyanjoyce @Siew_C_Ng @gilkaplan @JeanFredericCo1 @MichaelKappel12

English

Secure IBD@SecureIBD·21 May

THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19... by @ManasiAgrawalMD DDW ePoster Library; May 21 2021; 319644 eposters.ddw.org/ddw/2021/ddw-2… @EJBrenner_MD @ryanungaro @MichaelKappel12 @JeanFredericCo1

English

Secure IBD@SecureIBD·21 May

THE EFFECTS OF COMORBIDITIES ON COVID-19... by Rajen Parekh DDW ePoster Library; May 21 2021; 319646 eposters.ddw.org/ddw/2021/ddw-2… @EJBrenner_MD @MichaelKappel12 @ryanungaro @ManasiAgrawalMD @JeanFredericCo1

English

Secure IBD retweetledi

Millie Long@MLongMD·30 Nis

We are pleased to report that we have hit the 3000 mark in IBD patients enrolled in PREVENT COVID (a study of COVID-19 vaccination). Our team pledges to share results with patients in real time. Check out preliminary results here (>90% with titers) ibdpartners.org/preventcovid/r…

English

152

Secure IBD@SecureIBD·23 Nis

@ManasiAgrawalMD @EJBrenner_MD @ryanungaro @MichaelKappel12 @JeanFredericCo1

QAM

Secure IBD@SecureIBD·23 Nis

Read our paper on VDZ outcomes in #IBD, out in JCC @Y_ECCO_IBD 👉🏻Compared to all other meds, VDZ use was not a/w hospitalization or severe #COVID19 👉🏻Compared to TNFi monotherapy, VDZ monotherapy was a/w hospitalization, but not severe #COVID19 academic.oup.com/ecco-jcc/advan…

English

Keşfet

@EJBrenner_MD @ryanungaro @MichaelKappel12 @JeanFredericCo1 @Siew_C_Ng @gilkaplan @Flaviostein @JamesLewisGIEpi